Restricted accessResearch articleFirst published online 2000-12
Hyperthermic intraoperative intraperitoneal chemotherapy for peritoneal carcinomatosis and sarcomatosis using a cardioplegia heat exchanger and a two-pump system: a case report
A 34-year-old male diagnosed with pseudomyxoma peritoneii presented for an exploratory laparotomy and hyperthermic intraoperative intraperitoneal chemotherapy. A circuit using two roller pumps and a cardioplegia administration set was assembled to deliver the chemotherapy perfusate at a consistent temperature. The authors discuss a case in which this treatment modality was used, describing the perfusionist’s role and the circuit design.
Get full access to this article
View all access options for this article.
References
1.
Speyer JL , Collins JM , Dedrick RLet al.Phase I and pharmacological studies of 5-fluorouracil administered intraperitoneally . Cancer Res1980; 40: 567-572 .
2.
Sugarbaker PH.Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis . Semin Surg Oncol1998; 14: 254-261 .
3.
Sugarbaker PH.Intraperitoneal chemotherapy and cytoreductive surgery manual for physicians and nurses, 2nd edn.Grand Rapids, MI: Ludann Company , 1995.
4.
Sugarbaker PH.Management of peritoneal surface malignancy using intraperitoneal chemotherapy and cytoreductive surgery. A manual for physicians and nurses, 3rd edn.Grand Rapids, MI: Ludann Company , 1998.
5.
White SK , Stephens AD , Sugarbaker PH.Hyperthermic intraoperative intraperitoneal chemotherapy safety considerations . AORN J1996; 63: 716-724 .
